Compugen welcomes Dr Jean-Pierre Bizzari to its Board of Directors
– ISRAEL, Holon – Compugen Ltd. (NASDAQ:CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today the appointment of Jean-Pierre Bizzari, M.D.,…